Back to Search
ASHRAF BADROS, M.D.
M.D.
Medical Oncology Physician
NPI: 1821038241IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
D42593(MD)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
OTHER
Class of 1985
Research & Publications (20)
Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.
PMID 19671864·Clin Cancer Res·2009
3-trial
Natural history of osteonecrosis of the jaw in patients with multiple myeloma.
PMID 19018084·J Clin Oncol·2008
8-other
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
PMID 17654660·Cancer·2007
3-trial
Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.
PMID 16484704·J Clin Oncol·2006
8-other
Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.
PMID 17229337·Clin Lymphoma Myeloma·2006
3-trial
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients.
PMID 15867202·J Clin Oncol·2005
3-trial
Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait.
PMID 16555432·Clin Adv Hematol Oncol·2005
5-case
Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic stem cell support.
PMID 19525301·J Oncol Pharm Pract·2010
3-trial
A novel bioassay model to determine clinically significant bisphosphonate levels.
PMID 19653010·Support Care Cancer·2009
8-other
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.
PMID 19036117·Br J Haematol·2009
4-observational
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.
PMID 19471019·Blood·2009
3-trial
Prevalence and significance of vitamin D deficiency in multiple myeloma patients.
PMID 18485049·Br J Haematol·2008
8-other
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
PMID 17545538·Clin Cancer Res·2007
3-trial
Multiple myeloma and renal cell carcinoma possible association.
PMID 17701606·Leuk Lymphoma·2007
5-case
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
PMID 18000495·Clin Adv Hematol Oncol·2007
8-other
Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
PMID 16490847·Arch Dermatol·2006
5-case
Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation.
PMID 16755571·Am J Hematol·2006
5-case
Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma.
PMID 16758246·Skeletal Radiol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 22 S. GREENE ST
BALTIMORE, MD 21263 - Phone
- (410) 328-1230
Quick Facts
- NPI
- 1821038241
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile